EP Patent

EP1372602B1 — Flexible microchip devices for ophthalmic and other applications

Assigned to Dare MB inc · Expires 2007-04-18 · 19y expired

What this patent protects

Methods and systems are provided for delivering drug to the eye. The method and system may include implanting into the eye a device which comprises two or more discrete reservoirs, each reservoir containing a drug; and directing focused light to the implanted device to open a fir…

USPTO Abstract

Methods and systems are provided for delivering drug to the eye. The method and system may include implanting into the eye a device which comprises two or more discrete reservoirs, each reservoir containing a drug; and directing focused light to the implanted device to open a first one of the reservoirs and thereby permit the drug to diffuse from the first reservoir to the patient's eye.

Drugs covered by this patent

Patent Metadata

Patent number
EP1372602B1
Jurisdiction
EP
Classification
Expires
2007-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Dare MB inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.